DrugsControl Media Services

News Detail

Bumper crop of new drugs fails to lift big pharma R&D returns (14-12-2017)

LONDON, 14 DEC 2017 - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.


In fact, projected returns at 12 of the wor......
View Details

Source : Reuters

Related News